Remove 2008 Remove Dosage Remove Vaccines
article thumbnail

Prednisone for gout: Dosage, safety, and more

The Checkup by Singlecare

What is the right dosage of prednisone for gout? Used as a prophylactic to prevent future attacks, Dr. Downey says the dosage is typically only 5 mg. So, anyone taking it should avoid people who have highly infectious diseases like the flu or who recently received a live vaccine.

Dosage 94
article thumbnail

Evgenyi Shalaev, PhD

Blog: Ask a Student Pharmacist

Publications E Shalaev , W Wang, LA Gatlin (2008). Hastedt, Eds, Drugs and the Pharmaceutical Sciences (2008), 175 (Protein Formulation and Delivery (2nd Edition)), pp. In : Lyophilized Biologics and Vaccines: Modality-Based Approaches. Rational choice of excipients for use in lyophilized formulations. McNally, JE.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence

ISPE

Jaguar Gene Therapy is building a $125 million facility in RTP to manufacture adeno-associated virus (AAV)-based gene therapies, Beam Therapeutics is constructing an $83 million plant to develop precision medicines, and IQVIA, a CRO, opened an innovation lab in the park in 2021, focusing on bioanalytics, vaccines, biomarkers, and genomics.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S. In the Moderna COVID-19 vaccine contamination case, three lots of the five lots affected, totaling 1.63 How Did 75M J&J Vaccines Get Ruined?

article thumbnail

Regulatory Landscape for Raw Materials: CMC Considerations

ISPE

During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. Published 2008. Published May 2012. Guidance for Industry.